Valneva+3.92%
Valneva's COVID vaccine neutralizes Omicron
Valneva SE announced on Wednesday that antibodies induced by three doses of Valneva's vaccine candidate against COVID-19 neutralize the Omicron strain, as reported by the company in a statement published on its website.
According to the findings, all study samples (30) showed neutralizing antibodies against the Delta variant, and 26 of them (87%) presented neutralizing antibodies against the Omicron strain. After trading at $30.26 earlier in the session, following the announcement of the study, the company's shares were up 40.68% to $46.10 at 1:29 pm ET.
"We are extremely pleased with these results, which confirm the potential for broad-spectrum protection of our inactivated, adjuvanted whole virus vaccine and its ability to address currently circulating variants of concern," emphasized Juan Carlos Jaramillo, Chief Medical Officer of Valneva.